FitzpatrickMMWaltersMDTrompeterRSDillonMJBarrattTM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J Pediatr. 1993;122:532-537.
5.
AricetaGBesbasNJohnsonS; European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24:687-696.
6.
BernsJSKaplanBSMackowRCHefterLG. Inherited hemolytic uremic syndrome in adults. Am J Kidney Dis. 1992;19:331-334.
7.
CaprioliJNorisMBrioschiS; International Registry of Recurrent and Familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108:1267-1279.
8.
Sellier-LeclercALFremeaux-BacchiVDragon-DureyMA; French Society of Pediatric Nephrology. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2007;18:2392-2400.
9.
NorisMRuggenentiPPernaA. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol. 1999;10: 281-292.
BradyTMFeldLG. Pediatric approach to hypertension. Semin Nephrol. 2009;29:379-388.
12.
GarovicVDHilliardAATurnerST. Monogenic forms of low-renin hypertension. Nat Clin Pract Nephrol. 2006;2:624-630.
13.
LapeyraqueALWagnerEPhanV. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations. Pediatr Nephrol. 2008;23:1363-1366.
14.
SalandJMRuggenentiPRemuzziG. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2009;20:940-949.
15.
NürnbergerJPhilippTWitzkeO. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009;360:542-544.